ErlySign Secures INR 16 Crore in Pre-Series A Funding from Investor Ashish Kacholia
The investment, advised by DerivativeSaint—a boutique private equity and venture capital advisory firm—marks a pivotal moment for CURO Biosciences.
Global Diagnostics Market | 16/01/2025 | By Aishwarya | 343
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy